You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

adenoviral vector

Showing 1 - 25 of 694
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Cancer, Epithelial Tumor Trial in United States (NG-641)

Recruiting
  • Metastatic Cancer
  • Epithelial Tumor
  • NG-641
  • Los Angeles, California
  • +5 more
Jan 16, 2023

SARS-CoV-2, Covid19 Trial in Brussels (Serological testing)

Recruiting
  • SARS-CoV-2
  • Covid19
  • Serological testing
  • Brussels, Belgium
    UZ Brussel
May 17, 2022

Covid19 Trial in Cypress (VXA-CoV2-1)

Completed
  • Covid19
  • VXA-CoV2-1
  • Cypress, California
    WCCT
Jan 17, 2023

Secondary Lymphedema Trial in Helsinki, Tampere, Turku (Lymfactin® [1 x 10E10 vp], Lymfactin® [1 x 10E11 vp])

Active, not recruiting
  • Secondary Lymphedema
  • Lymfactin® [1 x 10E10 vp]
  • Lymfactin® [1 x 10E11 vp]
  • Helsinki, Finland
  • +2 more
Mar 16, 2022

Norovirus Infections Trial in Cypress (VXA-G1.1-NN)

Completed
  • Norovirus Infections
  • VXA-G1.1-NN
  • Cypress, California
    AltaSciences LA
Apr 27, 2022

Norovirus Infections Trial in Cypress, New Orleans, Austin (VXA-GI.1.NN, Placebo Tablet)

Completed
  • Norovirus Infections
  • VXA-GI.1.NN
  • Placebo Tablet
  • Cypress, California
  • +2 more
Sep 19, 2022

Norovirus Infections Trial in Cypress (VXA-G1.1-NN)

Completed
  • Norovirus Infections
  • VXA-G1.1-NN
  • Cypress, California
    WCCT Global, Inc.
Sep 19, 2022

HIV Trial (VRC-HIVDNA016-00-VP, VRC-HIVADV014-00-VP, VRC-HIVDNA016-00-VP )

Withdrawn
  • HIV Infections
  • VRC-HIVDNA016-00-VP
  • +3 more
  • (no location specified)
Oct 28, 2021

COVID-19 Trial in United States (VXA-CoV2-1.1-S, Placebo Tablets)

Recruiting
  • COVID-19
  • Long Beach, California
  • +3 more
Sep 19, 2022

Epithelial Tumor, Metastatic Cancer Trial in United Kingdom, United States (NG-350A plus Pembrolizumab)

Recruiting
  • Epithelial Tumor
  • Metastatic Cancer
  • NG-350A plus Pembrolizumab
  • Santa Monica, California
  • +3 more
May 4, 2022

Metastatic Cancer, Epithelial Tumor Trial in Santa Monica, Liverpool, Oxford (NG-641 in combination with Nivolumab)

Recruiting
  • Metastatic Cancer
  • Epithelial Tumor
  • NG-641 in combination with Nivolumab
  • Santa Monica, California
  • +2 more
Mar 16, 2022

Secondary Lymphedema Trial in Finland, Sweden (Lymfactin® (1x10E11 vp), Placebo)

Active, not recruiting
  • Secondary Lymphedema
  • Lymfactin® (1x10E11 vp)
  • Placebo
  • Helsinki, Finland
  • +4 more
Mar 16, 2022

HIV Trial in United States (DNA plasmid vaccine, Recombinant adenoviral serotype 5 (rAD5) vector vaccine, DNA vaccine )

Terminated
Has Results
  • HIV Infections
  • DNA plasmid vaccine
  • +3 more
  • Birmingham, Alabama
  • +21 more
Oct 13, 2021

Pediatric Brain Tumor, Diffuse Intrinsic Pontine Glioma Trial in San Francisco, Chicago, Boston (Ad-RTS-hIL-12, Oral Veledimex -

Terminated
  • Pediatric Brain Tumor
  • Diffuse Intrinsic Pontine Glioma
  • Ad-RTS-hIL-12
  • +2 more
  • San Francisco, California
  • +2 more
Nov 3, 2021

Norovirus Infection Trial in Cleveland (VXA-G1.1-NN, VXA-G2.4-NS, Placebo Tablets)

Completed
  • Norovirus Infection
  • VXA-G1.1-NN
  • +2 more
  • Cleveland, Ohio
    Rapid Medical Research
Apr 23, 2021

Glioblastoma Multiforme, Anaplastic Oligoastrocytoma Trial in United States (Ad-RTS-hIL-12, veledimex)

Completed
  • Glioblastoma Multiforme
  • Anaplastic Oligoastrocytoma
  • Los Angeles, California
  • +5 more
Sep 21, 2021

Transitional Cell Carcinoma, Bladder Cancer, Carcinoma in Situ Trial in United States (CG0070 Adenovirus Vector, Control Arm:

Terminated
  • Transitional Cell Carcinoma
  • +3 more
  • CG0070 Adenovirus Vector
  • Control Arm: Quadruple Choice
  • Phoenix, Arizona
  • +6 more
Apr 12, 2021

HIV Trial in United States (VRC-HIVADV014-00-VP)

Completed
  • HIV Infections
  • VRC-HIVADV014-00-VP
  • Baltimore, Maryland
  • +7 more
Oct 13, 2021

HIV Trial in United States (DNA Vaccine, DNA Vaccine , rAd35)

Completed
  • HIV Infections
  • DNA Vaccine
  • +5 more
  • Birmingham, Alabama
  • +9 more
Oct 13, 2021

Breast Cancer Trial in Los Angeles (Ad-sig-hMUC-1/ecdCD40L vaccine)

Withdrawn
  • Breast Cancer
  • Ad-sig-hMUC-1/ecdCD40L vaccine
  • Los Angeles, California
    Jonsson Comprehensive Cancer Center at UCLA
Jul 29, 2020

HIV Trial run by the NIAID (VRC-HIVADV014-00-VP)

Completed
  • HIV Infections
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Dec 14, 2019

Chronic Hepatitis B Trial in Hong Kong, Auckland (VRON-0200-AdC6, VRON-0200-AdC7)

Recruiting
  • Chronic Hepatitis B
  • VRON-0200-AdC6
  • VRON-0200-AdC7
  • Hong Kong, Hong Kong
  • +1 more
Oct 6, 2023

AIDS Vaccines, HIV, HIV-1 Trial run by the NIAID (VRC-HIVADV027-00-VP, VRC-HIVADV038-00-VP)

Completed
  • AIDS Vaccines
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Dec 13, 2019

COVID-19 Trial in Adelaide (SpikoGen vaccine)

Not yet recruiting
  • COVID-19
  • SpikoGen vaccine
  • Adelaide, South Australia, Australia
    ARASMI
Sep 13, 2022

Vaccination Against COVID-19 in Pregnant and Lactating Belgium

Active, not recruiting
  • Covid19
  • COVID-19 vaccine
  • Antwerp, Belgium
    Centre for the Evaluation of Vaccination
Nov 15, 2022